Rehabilitation After Arthroscopic Partial Meniscectomy

June 8, 2021 updated by: Hilal Yeşil

Water-Based vs. Land-Based Rehabilitation After Arthroscopic Partial Meniscectomy in Middle-Aged Active Patients With a Degenerative Meniscal Tear: A Randomized, Controlled Study

Water-Based vs. Land-Based Rehabilitation After Arthroscopic Partial Meniscectomy in Middle-Aged Active Patients with a Degenerative Meniscal Tear: A Randomized, Controlled Study

Study Overview

Status

Completed

Conditions

Detailed Description

In this study, we aimed to determine and compare the benefits of water-based exercise (WBE) and land-based exercise (LBE) on pain, functionality, and quality of life after arthroscopic partial meniscectomy (APM). Middle-aged (35-50), active 30 patients having APM for a degenerative meniscal tear randomized into LBE (n=15) and WBE (n=15) groups. The pain level (visual analogue scale [VAS]), isokinetic muscle strength, quality of life (Short Form-36 [SF-36]), and function level (single-leg hop test and Lysholm questionnaire) were evaluated prior to treatment and at follow-up visits at the fourth and eighth week after surgery. The exercise sessions were conducted 3 times a week for 4 weeks in both groups.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Afyon
      • Merkez, Afyon, Turkey, 0300
        • Hilal Yeşil

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: The inclusion criteria comprised a non-locked painful knee of more than 1 month, age between 35-50 years, a clinical history and examination compatible with degenerative meniscus, positive findings of a degenerative meniscal tear visible with magnetic resonance imaging (MRI), no response to nonoperative treatment of at least 3 months after onset of symptoms, and no evidence of advanced osteoarthritis (OA) on X-rays or MRI

Exclusion Criteria: The exclusion criteria employed were advanced knee OA, systemic inflammatory disease, a concurrent tear of posterior cruciate ligament, a concurrent collateral ligament repair, other problems causing knee pain (e.g., hip and ankle pathologies), a history of cardiopulmonary disease that could limit isokinetic and functional testing, an unstable medical condition, a serious cognitive deficit, a psychiatric problem, no capacity for independent walking and standing, an open wound on the skin, or pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Land based exercise
The patients who had land based exercise
Active Comparator: Water based exercise
The patients who had water based exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline VAS (visual analog scale) at 4th and 8th week
Time Frame: up to 8 weeks
The patients were asked to make an assesment of their pain level between 0 and 10 scale
up to 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline isokinetic muscle strength at 4th and 8th week
Time Frame: up to 8 weeks
Isokinetic knee extensor muscle strength of the patients was measured with an isokinetic dynamometer. The test was repeated 10 times at the velocity of 60°/second and 180°/second and peak torque (Nm) measurements were recorded .
up to 8 weeks
Change from baseline quality of life (short form 36) at 4th and 8th week
Time Frame: up to 8 weeks
The physical and mental health summary scores were the primary components used. Scoring is on a scale of 0 to 100 and a higher score reflects better health-related quality of life.
up to 8 weeks
Change from baseline Single-leg hop test at 4th and 8th week
Time Frame: up to 8 weeks
The patient stands on one foot with the big toe touching a line marked on the floor. The participant asked to hop forward as far as possible using the same leg with their arms swing freely on both sides of the body. Distance is measured from the starting point to the heel of the landing leg.
up to 8 weeks
Change from baseline Lysholm questionnaire at 4th and 8th week
Time Frame: up to 8 weeks
Eight subtitles are scored differently (limping or use of support: 5 points, locking sensation: 15 points, joint instability and pain: 25 points, swelling: 10 points, stair climbing: 10 points, and squatting: 5 points). The highest and optimal total score is 100 points
up to 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Murat Yesil, MD, Afyonkarahisar Health Sciences University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2018

Primary Completion (Actual)

October 10, 2019

Study Completion (Actual)

October 10, 2019

Study Registration Dates

First Submitted

June 8, 2021

First Submitted That Met QC Criteria

June 8, 2021

First Posted (Actual)

June 14, 2021

Study Record Updates

Last Update Posted (Actual)

June 14, 2021

Last Update Submitted That Met QC Criteria

June 8, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • MYHY

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe